Kyverna Therapeutics (KYTX) Q1 2025 Earnings

27MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.12
-0.97
-0.82
-0.67

Details

Expected EPS
-0.841292
Actual EPS
-0.867785
Surprise EPS
-0.03
Surprise Percent
+3.15%

Description

Kyverna Therapeutics (KYTX) has reported earnings of -0.867785 per share for Q1 2025.

0 Comments

Share your thoughts